An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer
Prognosis and prediction of adjuvant chemotherapy response in non-small cell lung cancer can have significant clinical impact. Here, the authors show that differential expression of a 29 extracellular matrix gene indicator, EPPI, can predict patient outcome.
Guardado en:
Autores principales: | Su Bin LIM, Swee Jin TAN, Wan-Teck LIM, Chwee Teck LIM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1415769e294f48ad9e9ce5914015f9ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prognostic Matrisomal Gene Panel and Its Association with Immune Cell Infiltration in Head and Neck Carcinomas
por: Yuri Belotti, et al.
Publicado: (2021) -
Single molecule and multiple bond characterization of catch bond associated cytoadhesion in malaria
por: Ying Bena Lim, et al.
Publicado: (2017) -
Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
por: Moonkyoo Kong, et al.
Publicado: (2021) -
Emergent patterns of collective cell migration under tubular confinement
por: Wang Xi, et al.
Publicado: (2017) -
Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression
por: Wen Cai Zhang, et al.
Publicado: (2016)